26 results
Thumbnail

D2.100 - The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors

Thumbnail

D2.111 - Wheeze phenotypes in infants whose mothers have asthma

Thumbnail

D2.99 - A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis

Thumbnail

D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma

Thumbnail

D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity

Thumbnail

D2.104 - Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma

Thumbnail

D2.105 - Clinical remission of severe asthma: 5-year follow-up

Thumbnail

D2.106 - Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness

Thumbnail

D2.107 - Effect of n-3 long-chain polyunsaturated fatty acid and vitamin D supplementation on human lung organoids

Thumbnail

D2.108 - Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain

Thumbnail

D2.109 - Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study

Thumbnail

D2.110 - MicroRNA Signatures of Pediatric Obesity-Associated Asthma: Identifying Molecular Links Between Obesity and Asthma in Children

Thumbnail

D2.112 - The Impact of Obesity in Asthma and Small Airway Dysfunction: Prevalence, Clinical characteristics, and Predictors

Thumbnail

D2.114 - Insights from the BREATHE Study: Comorbidity Burden and Biomarker Trends in Severe Asthma Patients

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy